0000929638-23-002513.txt : 20230912 0000929638-23-002513.hdr.sgml : 20230912 20230912201111 ACCESSION NUMBER: 0000929638-23-002513 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230831 FILED AS OF DATE: 20230912 DATE AS OF CHANGE: 20230912 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schlorff Eric CENTRAL INDEX KEY: 0001949738 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39927 FILM NUMBER: 231251361 MAIL ADDRESS: STREET 1: C/O SEASTAR MEDICAL, INC. STREET 2: 3513 BRIGHTON BOULEVARD, SUITE 410 CITY: DENVER STATE: CO ZIP: 80216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SeaStar Medical Holding Corp CENTRAL INDEX KEY: 0001831868 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 853681132 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3513 BRIGHTON BLVD STREET 2: SUITE 410 CITY: DENVER STATE: CO ZIP: 80216 BUSINESS PHONE: 844-427-8100 MAIL ADDRESS: STREET 1: 3513 BRIGHTON BLVD STREET 2: SUITE 410 CITY: DENVER STATE: CO ZIP: 80216 FORMER COMPANY: FORMER CONFORMED NAME: LMF Acquisition Opportunities Inc DATE OF NAME CHANGE: 20201109 4 1 form4.xml X0508 4 2023-08-31 0001831868 SeaStar Medical Holding Corp ICU 0001949738 Schlorff Eric C/O SEASTAR MEDICAL HOLDING CORPORATION 3513 BRIGHTON BLVD., SUITE 410 DENVER CO 80216 true true Chief Executive Officer false Common Stock, par value $0.0001 per share 2023-08-31 4 A 0 35178 0 A 738753 D Stock Option (Right to Buy) 1.84 2033-04-06 Common Stock 99724 99724 D Stock Option (Right to Buy) 10 2029-03-01 Common Stock 17986 17986 D Stock Option (Right to Buy) 0.53 2030-02-20 Common Stock 83985 83985 D The securities reported in this transaction were issued to the Reporting Person in lieu of cash compensation previously approved by the Compensation Committee. All options reported herein will vest, subject to continued service, on April 6, 2024. These options are fully vested. The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021. /s/ Eric Schlorff 2023-09-12